US Stock MarketDetailed Quotes

ANAB AnaptysBio

Watchlist

24.960
-0.160-0.64%

Close Nov 29 13:00 ET

24.960
0.0000.00%

Post 17:01 ET

759.50MMarket Cap-4125P/E (TTM)

AnaptysBio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AnaptysBio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 10.950M	--
--	2024/Q4	-- / 10.105M	--
--	2024/Q3	30.017M / 8.166M	--
--	2024/Q2	10.971M / 22.757M	--
--	2024/Q1	7.179M / 3.971M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 10.950M--

--2024/Q4-- / 10.105M--

--2024/Q330.017M / 8.166M--

--2024/Q210.971M / 22.757M--

--2024/Q17.179M / 3.971M--

Unlock Free Earnings Estimates

Open Account

AnaptysBio Earnings Reports

AnaptysBio | 10-Q: Q3 2024 Earnings Report

Nov 5 16:22 ET

AnaptysBio | 8-K: Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update

Nov 5 16:21 ET

AnaptysBio | 10-Q: Q2 2024 Earnings Report

Aug 5 16:27 ET

AnaptysBio | 8-K: Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update

Aug 5 16:23 ET

Analyst Rating

Updated: Nov 19, 2024

Strong Buy

Buy
84.62%
Hold
15.39%
Sell
0.00%

Price Target

No Data

Heat List

Overall